Stocks
Viveve Medical (VIVE) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 1 364% | 640.3% | 790.2% | 656.2% | 2 120% | 1 466% | |||
| Changes by years, y/y, % | -1 904pp | -724pp | +150pp | -134pp | +1 463pp | -8.3% | |||
Viveve Medical. R&D/CAPEX, %
Viveve Medical. R&D/CAPEX, changes, pp
Viveve Medical (VIVE) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | LTM ? | |||
| R&D/CAPEX, % | 3 208% | 973.1% | 4 367% | 3 256% | 932.6% | 1 466% | ||
| Changes by years, y/y, % | +2 412pp | +608pp | +2 097pp | -27 887pp | -2 276pp | |||
| Changes by quarters, q/q, % | -27 935pp | -2 235pp | +3 394pp | -1 111pp | -2 323pp | |||
